https://www.cureus.com/articles/120380-the-efficacy-of-sodium-glucose-cotransporter-2-inhibitors-in-improving-morbidity-and-mortality-of-heart-failure-a-systematic-review
Cardiovascular disease (CVD) is the leading cause of mortality in patients with type 2 diabetes mellitus (DM) worldwide. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) were initially developed for treating patients with type 2 DM. The four major drugs dev…
Create an account or login to join the discussion